These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28061845)

  • 1. Parity and bladder cancer risk: a dose-response meta-analysis.
    Bai Y; Wang X; Yang Y; Tang Y; Wang J; Han P
    BMC Cancer; 2017 Jan; 17(1):31. PubMed ID: 28061845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.
    Davis-Dao CA; Henderson KD; Sullivan-Halley J; Ma H; West D; Xiang YB; Gago-Dominguez M; Stern MC; Castelao JE; Conti DV; Pike MC; Bernstein L; Cortessis VK
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1156-70. PubMed ID: 21493870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis.
    Dietrich K; Demidenko E; Schned A; Zens MS; Heaney J; Karagas MR
    Eur J Cancer; 2011 Mar; 47(4):592-9. PubMed ID: 21067913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies.
    Guan HB; Wu L; Wu QJ; Zhu J; Gong T
    PLoS One; 2014; 9(3):e92738. PubMed ID: 24658609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Wang Q; Huang Q; Zeng Y; Liang JJ; Liu SY; Gu X; Liu JA
    Osteoporos Int; 2016 Jan; 27(1):319-30. PubMed ID: 26439242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parity and kidney cancer risk: evidence from epidemiologic studies.
    Guan HB; Wu QJ; Gong TT
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2345-53. PubMed ID: 24108791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer, parity, and age at first birth.
    Cantor KP; Lynch CF; Johnson D
    Cancer Causes Control; 1992 Jan; 3(1):57-62. PubMed ID: 1536914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of parity and the risk of gallbladder cancer: a systematic review and dose-response meta-analysis of observational studies.
    Guo P; Xu C; Zhou Q; Zhou J; Zhao J; Si Z; Shen C; Feng C
    Arch Gynecol Obstet; 2016 May; 293(5):1087-96. PubMed ID: 26408005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and risk of bladder cancer: a meta-analysis of cohort studies.
    Qin Q; Xu X; Wang X; Zheng XY
    Asian Pac J Cancer Prev; 2013; 14(5):3117-21. PubMed ID: 23803089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies.
    Zhao L; Tian X; Duan X; Ye Y; Sun M; Huang J
    Oncotarget; 2017 May; 8(20):33990-34000. PubMed ID: 28389625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of parity and the risk of rheumatoid arthritis in women: A dose-response meta-analysis of observational studies.
    Ren L; Guo P; Sun QM; Liu H; Chen Y; Huang Y; Cai XJ
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1428-1440. PubMed ID: 28613016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.
    Wu QJ; Li YY; Tu C; Zhu J; Qian KQ; Feng TB; Li C; Wu L; Ma XX
    Sci Rep; 2015 Sep; 5():14243. PubMed ID: 26373341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parity and risk of colorectal cancer: a dose-response meta-analysis of prospective studies.
    Guan HB; Wu QJ; Gong TT; Lin B; Wang YL; Liu CX
    PLoS One; 2013; 8(9):e75279. PubMed ID: 24098689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies.
    Tzelves L; Xenou D; Skolarikos A; Varkarakis I; Deliveliotis C; Terpos E; Stamatelopoulos K; Sergentanis TN; Psaltopoulou T
    J BUON; 2021; 26(3):1040-1055. PubMed ID: 34268971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis.
    Xie Y; Xu P; Wang M; Zheng Y; Tian T; Yang S; Deng Y; Wu Y; Zhai Z; Hao Q; Song D; Zhang D; Dai Z
    Aging (Albany NY); 2020 Jan; 12(2):1545-1562. PubMed ID: 31968309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.
    Afshari M; Janbabaei G; Bahrami MA; Moosazadeh M
    PLoS One; 2017; 12(6):e0178527. PubMed ID: 28586371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
    Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y
    Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.
    Unar-Munguía M; Torres-Mejía G; Colchero MA; González de Cosío T
    J Hum Lact; 2017 May; 33(2):422-434. PubMed ID: 28196329
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.